Benefit of Surveillance for Pancreatic Cancer in High-Risk Individuals: Outcome of Long-Term Prospective Follow-Up Studies From Three European Expert Centers [Cancer Prevention and Control]

Conclusion Surveillance of CDNK2A mutation carriers is relatively successful, detecting most PDACs at a resectable stage. The benefit of surveillance in families with FPC is less evident.

http://jco.ascopubs.org/cgi/content/short/34/17/2010?rss=1

Source: Journal of Clinical Oncology - May 31, 2016 Category: Cancer & Oncology Authors: Vasen, Ibrahim, Ponce, Slater, Matthai, Carrato, Earl, Robbers, van Mil, Potjer, Bonsing, de Vos tot Nederveen Cappel, Bergman, Wasser, Morreau, Kloppel, Schicker, Steinkamp, Figiel, Esposito, Mocci, Vazquez-Sequeiros, Sanjuanbenito, Munoz-Beltran, Montan Tags: Prognostic Studies, Population and observational studies (SEER, WHI observational, etc.) Cancer Prevention and Control Source Type: research